This bill aims to eliminate the requirement for prior authorization when prescribing certain interchangeable drugs. Specifically, it states that a carrier, which includes various health insurance entities, cannot require prior authorization if the brand name drug or its generic version is unavailable. The bill defines prior authorization as the process used by carriers to assess the medical necessity of a covered service, and it emphasizes that this process should not be applied in the specified circumstances.

The legislation is designed to streamline access to necessary medications by removing barriers that may delay treatment when specific drug options are not available. It is set to take effect immediately upon enactment, reflecting a commitment to improving healthcare accessibility for patients in New Jersey.